News | Proton Therapy | March 30, 2016

IBA to Install First Proton Therapy Center in Belgium

Center with Proteus One system scheduled to open in 2018

IBA, Belgium, first proton therapy center, UZ Leuven, KU Leuven, Proteus One

March 30, 2016 — IBA (Ion Beam Applications SA) announced it has signed a contract with the University Hospitals Leuven (UZ Leuven) and Katholieke Universiteit Leuven (KU Leuven) to install Belgium’s first proton therapy center. The project will be conducted in collaboration with Université Catholique de Louvain (UCL), Cliniques universitaires Saint-Luc and other Belgian universities. IBA was awarded the contract following a comprehensive European public tender conducted by UZ Leuven.

IBA will equip the new center with its Proteus One system. The contract will also include a long-term maintenance agreement. The typical end-user price for a Proteus One system with such a maintenance contract is between EUR 35 and 40 million. This new center is expected to open in 2018.

Marc Decramer, chief executive officer of UZ Leuven, commented, “We are very pleased to announce that we will be working with IBA. The UZ Leuven mission is to deliver the highest quality and most innovative patient care with unrelenting attention to clinical excellence, patient care and patient safety. It was therefore a natural decision for us to equip our hospital with a proton therapy solution as it is the most targeted treatment in the fight against cancer. Following a comprehensive public tender, we have chosen IBA because it provided the proton therapy solution that best fitted our needs.”

In proton therapy, protons deposit the majority of their effective energy within a precisely controlled range, directly within the tumor, sparing healthy surrounding tissue. Higher doses can be delivered to the tumor without increasing the risk of side effects and long-term complications, thereby improving patient outcomes and quality of life.

Proteus One is equipped with pencil beam scanning, a technology that offers a millimeter precision treatment, delivered with very high levels of conformity and dose uniformity, even in complex-shaped tumors, whilst at the same time sparing the surrounding healthy tissue.

For more information: www.iba-worldwide.com

Related Content

Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more
A model of the new, compact, single-room Varian ProBeam 360 system. The system is an example of the trend in proton therapy toward single-room, smaller systems and away from multi-room treatment centers. #ASTRO18 #ASTRO2018

A model of the new, compact, single-room Varian ProBeam 360 system. The system is an example of the trend in proton therapy toward single-room, smaller systems and away from multi-room treatment centers.

Feature | Proton Therapy | November 01, 2018 | Dave Fornell, Editor
A few of the big takeaways from the American Societ...